The largest database of trusted experimental protocols

21 protocols using screenfect a plus

1

KSHV Lytic Replication Induction and Virus Titer Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The iSLK cells (1 × 105 cells) were transfected with either pCI-neo-3xFLAG empty plasmid or 3xFLAG-tagged ORF7 plasmid using Screenfect A plus (Wako, Tokyo, JAPAN), according to the manufacturer’s instructions, then simultaneously cultured with medium containing 8 μg/mL of Dox and 1.5 mM of NaB to induce lytic replication. After 3 days, culture supernatant was harvested and KSHV genomes were evaluated using real-time PCR. In addition to measuring KSHV genome, the virus titers in culture supernatants were also evaluated. The iSLK cells (1 × 106 cells) were transfected with ORF7-3xFLAG plasmid using Screenfect A plus (Wako) and treated with Dox and NaB. After 72 h, culture supernatants were collected and centrifuged at 15,000 rpm 10 min at room temperature, then each supernatant (200 μL) was mixed with 1 × 104 trypsinized HEK293T or HeLa cells. Polybrene (Sigma-Aldrich, MO, USA) was added to the cell mixture (8 μg/mL final concentration), and cells were placed into a 96-well plate. The 96-well plate was centrifuged at 1200× g for 1 h at room temperature. After 24 h, GFP-positive cells were counted by fluorescence microscopy.
+ Open protocol
+ Expand
2

Plasmid Transfection and Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transfected with the respective plasmids using a Screen Fect A or Screen Fect A Plus transfection kit (Fujifilm, Tokyo, Japan), in accordance with the manufacturer’s instructions. The medium was replaced 4 h after transfection. Transfected cells were generally used for experiments 48 h after transfection. Otherwise, G418 (2500 microgram/mL)-resistant clones were collected as stable clones.
We confirmed that FBD-102b cells were viable under each transfection experimental condition by verifying that attached trypan-blue-incorporating cells made up less than 5% of all cells in each culture.
+ Open protocol
+ Expand
3

Transfection and Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were transfected with the respective plasmids using a ScreenFect A or ScreenFect A Plus transfection kit (Fujifilm, Tokyo, Japan) according to the manufacturer’s instructions. The medium was replaced 4 h after transfection. Transfected cells were generally used for experiments 48 h after transfection in biochemical experiments. We confirmed that FBD−102b cells were viable under each experimental condition by verifying that the attached trypan-blue (Nacalai Tesque)-incorporating cells made up less than 5% of all the cells in each culture.
+ Open protocol
+ Expand
4

Inducing Lytic State in iSLK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The iSLK cells were transfected with each plasmid using ScreenFect A plus (Wako) according to the manufacturer’s instructions and the transfected cells were simultaneously cultured with medium containing Dox and NaB to induce the lytic state. After 72 h, the culture supernatants and cells were collected, and the amount of virus production and infectivity was assessed.
+ Open protocol
+ Expand
5

Cloning and Characterization of ACVRL1 Promoter

Check if the same lab product or an alternative is used in the 5 most similar protocols
The putative human ACVRL1 promoter sequence (GeneBank: NC_000012.12, position 51906383 to 51907627) was amplified by the forward primer; 5ʹ- GGGGGTACCATAACCAGGAGGCTAGG-3ʹ and the reverse primer; 5ʹ-TTTAAGCTTCGCGGCCGCAGTTG-3ʹ. The obtained fragment was then subcloned into pGL3-basic vector (Promega) at the KpnI and HindIII sites29 (link). The construct was verified by restriction digestion and DNA sequencing. The pGL3-basic vector containing the putative ACVRL1 promoter region and pNL1.1.TK [Nluc/TK] as a control vector were co-transfected by using ScreenFect A Plus (Wako) according to the manufacturer’s protocol. The promoter activity of ACVRL1 was determined by using Dual-Glo Luciferase Assay System (Promega). The cells were incubated with ruxolitinib (Novartis Pharmaceuticals) or stattic (Cayman Chemical) for 24 h prior to the luciferase assay. Each experiment was performed in duplicate.
+ Open protocol
+ Expand
6

Generating Recombinant KSHV Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
For maintenance, iSLK cells were cultured in growth medium of DMEM/fetal calf serum 10% containing 1 μg/mL puromycin (Fujifilm-Wako Chemicals, Osaka, Japan) and 0.25 mg/mL of G418 (Fujifilm-Wako Chemicals). KSHV BAC16 mutant (∆ORF34-BAC16) and its revertant (∆ORF34Rev-BAC16), as previously described (20 (link)), were transfected to iSLK cells using Screenfect A plus (Fujifilm-Wako Chemicals) according to the manufacturer’s instructions. Transfected cells were selected under 1000 μg/mL of hygromycin B (Fujifilm-Wako Chemicals) to establish doxycycline-inducible recombinant KSHV-producing cell lines (iSLK-∆34Rev and iSLK-∆34).
To establish stable ORF34-expressing cells for complementation, pCI-blast-3xFLAG-ORF34 and empty vector pCI-blast-3xFLAG were transfected into iSLK-∆34Rev and iSLK-∆34 cells, and transfected cells were selected and maintained in 10 μg/mL and 7.5 μg/mL of Blasticidin S (Fujifilm-Wako Chemicals), respectively. Thus, the stable cell lines iSLK-∆34Rev/pCI-blast-3xFLAG, iSLK-∆34/pCI-blast-3xFLAG, iSLK-∆34/pCI-blast-3xFLAG-ORF34WT, and iSLK-∆34/pCI-blast-3xFLAG-ORF34 mutants were established.
+ Open protocol
+ Expand
7

Overexpressing E-cadherin in EcadKO cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
EcadKO cells were transfected with a HA-tagged mouse E-cadherin plasmid (pCAGGS-E-cadherin HA) and pcDNA6/TR using Screen Fect A plus (Wako, Osaka, Japan). Blasticidin was used to select transfected clones.
+ Open protocol
+ Expand
8

MARCKS siRNA Transfection in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
ScreenFectA Plus (Wako) was employed for siRNA transfection procedures for both cell
lines. MARCKS siRNA (HSS180966) and negative control siRNA were purchased from Invitrogen
(Carlsbad, CA, U.S.A.). SH-SY5Y or EA.hy926 cells were mixed with 20 or 3.5 nM siRNA,
respectively, and then seeded in a 96-well plate or 35-mm dishes 2 days before
experiments.
+ Open protocol
+ Expand
9

PKM2 Knockdown in Oral Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PKM2 knockdown was carried out using small interfering RNA (siRNA) oligonucleotides (siPKM2) synthesized by Sigma-Aldrich (St. Loius, MO, USA). For negative control, siScramble (siScrbl) was also purchased from Sigma-Aldrich. siRNA was transfected into HSC-4 and SAS cells at 25 pmol/125 μl final concentrations with Screen Fect A plus (Wako, Osaka, Japan), using a forward transfection method according to the manufacture’s protocols.
+ Open protocol
+ Expand
10

Knockdown of PCP4/PEP19, ESR1 using siRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
For knockdown experiments, pre-designed siRNAs were used for knockdown of PCP4/PEP19 (ID: HSS181928), ESR1 (ID: VHS40913) and Stealth RNAi siRNA Negative Control was used as negative control (Thermo Fisher Scientific, Waltham, MA). The cells were transfected with siRNAs using Lipofectamine RNAiMAX in Opti-MEM I (Thermo Fisher Scientific) according to the manufacturer’s instructions. For the plasmid transfection, ScreenFect A plus (Wako Pure Chemical, Osaka, Japan) was used according to the manufacturer’s instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!